Literature DB >> 26435771

Stem cells: An eventual treatment option for heart diseases.

Joseph C Bilgimol1, Subbareddy Ragupathi1, Lakshmanan Vengadassalapathy1, Nathan S Senthil1, Kalimuthu Selvakumar1, M Ganesan1, Sadananda Rao Manjunath1.   

Abstract

Stem cells are of global excitement for various diseases including heart diseases. It is worth to understand the mechanism or role of stem cells in the treatment of heart failure. Bone marrow derived stem cells are commonly practiced with an aim to improve the function of the heart. The majority of studies have been conducted with acute myocardial infarction and a few has been investigated with the use of stem cells for treating chronic or dilated cardiomyopathy. Heterogeneity in the treated group using stem cells has greatly emerged. Ever increasing demand for any alternative made is of at most priority for cardiomyopathy. Stem cells are of top priority with the current impact that has generated among physicians. However, meticulous selection of proper source is required since redundancy is clearly evident with the present survey. This review focuses on the methods adopted using stem cells for heart diseases and outcomes that are generated so far with an idea to determine the best therapeutic possibility in order to fulfill the present demand.

Entities:  

Keywords:  Bone marrow stem cells; Heart diseases; Induced pluripotent stem cells; Mesenchymal stem cells; Progenitor cells; Stem cells

Year:  2015        PMID: 26435771      PMCID: PMC4591785          DOI: 10.4252/wjsc.v7.i8.1118

Source DB:  PubMed          Journal:  World J Stem Cells        ISSN: 1948-0210            Impact factor:   5.326


  92 in total

1.  Radiolabeled cell distribution after intramyocardial, intracoronary, and interstitial retrograde coronary venous delivery: implications for current clinical trials.

Authors:  Dongming Hou; Eyas Al-Shaykh Youssef; Todd J Brinton; Ping Zhang; Pamela Rogers; Erik T Price; Alan C Yeung; Brian H Johnstone; Paul G Yock; Keith L March
Journal:  Circulation       Date:  2005-08-30       Impact factor: 29.690

2.  Intracoronary bone marrow cell transfer after myocardial infarction: eighteen months' follow-up data from the randomized, controlled BOOST (BOne marrOw transfer to enhance ST-elevation infarct regeneration) trial.

Authors:  Gerd P Meyer; Kai C Wollert; Joachim Lotz; Jan Steffens; Peter Lippolt; Stephanie Fichtner; Hartmut Hecker; Arnd Schaefer; Lubomir Arseniev; Bernd Hertenstein; Arnold Ganser; Helmut Drexler
Journal:  Circulation       Date:  2006-03-06       Impact factor: 29.690

3.  Repair of acute myocardial infarction by human stemness factors induced pluripotent stem cells.

Authors:  Timothy J Nelson; Almudena Martinez-Fernandez; Satsuki Yamada; Carmen Perez-Terzic; Yasuhiro Ikeda; Andre Terzic
Journal:  Circulation       Date:  2009-07-20       Impact factor: 29.690

4.  Doubts over heart stem-cell therapy.

Authors:  Alison Abbott
Journal:  Nature       Date:  2014-05-01       Impact factor: 49.962

5.  Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction.

Authors:  Volker Schächinger; Sandra Erbs; Albrecht Elsässer; Werner Haberbosch; Rainer Hambrecht; Hans Hölschermann; Jiangtao Yu; Roberto Corti; Detlef G Mathey; Christian W Hamm; Tim Süselbeck; Birgit Assmus; Torsten Tonn; Stefanie Dimmeler; Andreas M Zeiher
Journal:  N Engl J Med       Date:  2006-09-21       Impact factor: 91.245

Review 6.  Cell-based cardiovascular repair and regeneration in acute myocardial infarction and chronic ischemic cardiomyopathy-current status and future developments.

Authors:  Christian Templin; Thomas F Lüscher; Ulf Landmesser
Journal:  Int J Dev Biol       Date:  2011       Impact factor: 2.203

Review 7.  Current status of cellular therapy for ischemic heart disease.

Authors:  Shafie Fazel; Gilbert H L Tang; Denis Angoulvant; Massimo Cimini; Richard D Weisel; Ren-Ke Li; Terrence M Yau
Journal:  Ann Thorac Surg       Date:  2005-06       Impact factor: 4.330

Review 8.  Stem cell therapy in patients with heart failure.

Authors:  Bojan Vrtovec; Gregor Poglajen; François Haddad
Journal:  Methodist Debakey Cardiovasc J       Date:  2013 Jan-Mar

9.  Functional impairment of hematopoietic progenitor cells in patients with coronary heart disease.

Authors:  Antonio Liguori; Carmela Fiorito; Maria Luisa Balestrieri; Ettore Crimi; Giuseppe Bruzzese; Sharon Williams-Ignarro; Maurizio D'Amora; Linda Sommese; Vincenzo Grimaldi; Pellegrino Biagio Minucci; Alfonso Giovane; Bartolomeo Farzati; Louis J Ignarro; Claudio Napoli
Journal:  Eur J Haematol       Date:  2007-12-07       Impact factor: 2.997

Review 10.  Stem cells in clinical practice: applications and warnings.

Authors:  Daniele Lodi; Tommaso Iannitti; Beniamino Palmieri
Journal:  J Exp Clin Cancer Res       Date:  2011-01-17
View more
  2 in total

1.  The transplantation of induced pluripotent stem cells into the cochleae of mature mice.

Authors:  Hengtao Zhu; Jing Chen; Lina Guan; Shan Xiong; Hongqun Jiang
Journal:  Int J Clin Exp Pathol       Date:  2018-09-01

Review 2.  Scientific Papers and Patents on Substances with Unproven Effects. Part 2.

Authors:  Sergei V Jargin
Journal:  Recent Pat Drug Deliv Formul       Date:  2019
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.